Skip to content

Collaborative Care for Depressed Elderly in Korea

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01626716
Enrollment
80
Registered
2012-06-25
Start date
2012-06-30
Completion date
2013-12-31
Last updated
2016-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Elderly, Korean, Collaborative Care

Brief summary

Late-life depression is associated with physical limitations, greater functional impairment, increased utilization and cost of health care, and suicide. Collaborative care, linking primary and mental health specialty care, has been shown to be effective for the treatment of late-life depression in primary care settings in Western countries. The primary aim of this project is to implement a depression care management intervention, and examine its effectiveness on the depressive symptoms of older patients in Korean primary care settings. Based on chronic disease management theory and previous Collaborative care management studies in western countries, we propose to test a Depression Care Management intervention,which includes care manager to support a primary care physician of depression in their old patients. Care manager'd role are monitoring the progress of treatment, supporting patient's adherence, educating patients/ family and facilitate communication between providers. Also psychiatrists provide consultation and supervision of care managers. Using a randomized controlled design, we will examine whether the Depression care management is an effective treatment for patients with late life depression in rural Korea. The primary outcome would be the improvement of depressive symptoms of patients in primary care setting.

Interventions

patients who assigned to the intervention group will take 7 times phone calls from case manager

Sponsors

National Clinical Research Coordination Center, Seoul, Korea
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 60 year or older * diagnosed depression based on DSM-IV criteria

Exclusion criteria

* impairment of hearing * dementia * other psychiatric disorders

Design outcomes

Primary

MeasureTime frameDescription
Reduced depression symptoms3 monthsHAMD (Hamilton Depression Ratind Scale) Difference HAMD score between the intervention and control group from baseline to 3 month follow-up

Secondary

MeasureTime frameDescription
Depression response and remissionhealth related quality of life3months and 6monthsHAMD (Hamilton Depression Ratind Scale) Depression response is defined by improvement 50% or more HAMD scores from baseline to each follow-up periods. Depression remission is defined by 7 or less of HAMD score at each follow-up periods
Reduced suicide ideation3 months and 6 monthsSSI (Beck's suicide ieation scale) Difference total SSI scores Between the two groups from baseline to each follow-up periods
Improvement of Quality of life3 months and 6 monthsEQ5D Difference EQ5D scores Between the two groups from baseline to each follow-up periods

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026